Kalyaan Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.53 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -38.55%
- Profit Growth 270.71%
- Ebitda 2.26%
- Net Worth 27.14%
- Total Assets 11.39%
About Kalyaan Diagnostics
Kalyaan Diagnostics Private Limited (KDPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 March 2011 and has a history of 13 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.53 M, as per Ministry of Corporate Affairs (MCA) records.
Sachin Rana and Pradeep Rana serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2011PTC215161
-
Company No.
215161
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Mar 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Kalyaan Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sachin Rana
|
Director | 30-Nov-2020 | Current |
|
Pradeep Rana
|
Director | 30-Nov-2020 | Current |
Financial Performance of Kalyaan Diagnostics.
Kalyaan Diagnostics Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 38.55% decrease. The company also saw a substantial improvement in profitability, with a 270.71% increase in profit. The company's net worth Soared by an impressive increase of 27.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kalyaan Diagnostics?
In 2019, Kalyaan Diagnostics had a promoter holding of 28.57% and a public holding of 71.43%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
N H Orchards LlpSachin Rana is a mutual person
-
Hint Publication Private Limited
Sachin Rana and Pradeep Rana are mutual person
-
Shrinathji-Hotel And Resorts (India) Private Limited
Sachin Rana and Pradeep Rana are mutual person
-
Fallon Reality Private Limited
Sachin Rana is a mutual person
-
Fullbort Infracon Private Limited
Sachin Rana is a mutual person
-
Anvesha Enterprises Private Limited
Sachin Rana is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kalyaan Diagnostics?
Unlock and access historical data on people associated with Kalyaan Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kalyaan Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kalyaan Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
